Source: Markets Insider

Onconova Therapeutics: Onconova stock slips after all-stock merger (NASDAQ:ONTX)

Onconova Therapeutics (ONTX) stock fell after the company acquire private biotech Trawsfynydd Therapeutics in all-stock deal. Read more here.

Read full article »
Onconova Therapeutics's Competitors | Onconova Therapeutics's News | Onconova Therapeutics's Financials
Stay up-to-date with the latest news on Onconova Therapeutics
Annual Revenue
$100K-5.0M
Employees
1-25
Steven M. Fruchtman's photo - President & CEO of Onconova Therapeutics

President & CEO

Steven M. Fruchtman

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Onconova Therapeutics